| Name | [4-(3-fluoroanilino)piperidin-1-yl]-(1H-imidazol-2-yl)methanone |
|---|
| Molecular Formula | C15H17FN4O |
|---|---|
| Molecular Weight | 288.32000 |
| Exact Mass | 288.13900 |
| PSA | 61.02000 |
| LogP | 2.27640 |
|
~%
920511-25-7 |
| Literature: Glaxo Group Limited Patent: US2008/312209 A1, 2008 ; Location in patent: Page/Page column 18 ; US 20080312209 A1 |
|
~54%
920511-25-7 |
| Literature: Westaway, Susan M.; Brown, Samantha L.; Conway, Elizabeth; Heightman, Tom D.; Johnson, Christopher N.; Lapsley, Kate; Macdonald, Gregor J.; MacPherson, David T.; Mitchell, Darren J.; Myatt, James W.; Seal, Jon T.; Stanway, Steven J.; Stemp, Geoffrey; Thompson, Mervyn; Celestini, Paolo; Colombo, Andrea; Consonni, Alessandra; Gagliardi, Stefania; Riccaboni, Mauro; Ronzoni, Silvano; Briggs, Michael A.; Matthews, Kim L.; Stevens, Alexander J.; Bolton, Victoria J.; Boyfield, Izzy; Jarvie, Emma M.; Stratton, Sharon C.; Sanger, Gareth J. Bioorganic and Medicinal Chemistry Letters, 2008 , vol. 18, # 24 p. 6429 - 6436 |